Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Athens

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Blood|January 1, 1973
Humoral stimulators of granulocyte productionG Rothstein, E H Hügl, P A Chervenick, et al.
The Journal of Clinical Investigation|September 1, 1971
STimulation of granulocytopoiesis by a diffusible factor in vivoG Rothstein, E H Hügl, C R Bishop, et al.
Cancer Treatment Reports|January 1, 1983
Management of patients with metastatic adenocarcinoma of unknown origin: a Southwest Oncology Group studyR A Shildt, P S Kennedy, T T Chen, et al.
Investigational New Drugs|May 1, 1993
Mitoxantrone (dihydroxyanthracenedione) in acute leukemia. An evaluation of two treatment schedules by the Southwest Oncology GroupJ H Saiki, W J Stuckey, J W Athens, et al.
Investigational New Drugs|January 1, 1983
Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast. A Southwest Oncology Group studyF E Smith, N Gad-el-Mawla, B Tranum, et al.
Cancer Treatment Reports|January 1, 1985
Tamoxifen therapy and colorectal adenocarcinoma: a Southwest Oncology Group studyF J Panettiere, C W Groppe, J W Athens, et al.
Cancer Treatment Reports|August 1, 1986
Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group StudyL Dabich, F E Bull, G Beltran, et al.
Cancer|November 15, 1986
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomasJ H Saiki, L H Baker, S E Rivkin, et al.
Breast Cancer Research and Treatment|January 1, 1983
Adjuvant therapy of breast cancer: the Southwest Oncology Group experienceW A Knight, S E Rivkin, H Glucksberg, et al.
Cancer|November 15, 1984
Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group studyB Hoogstraten, N Gad-el-Mawla, T R Maloney, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Blood|January 1, 1973
Humoral stimulators of granulocyte productionG Rothstein, E H Hügl, P A Chervenick, et al.
The Journal of Clinical Investigation|September 1, 1971
STimulation of granulocytopoiesis by a diffusible factor in vivoG Rothstein, E H Hügl, C R Bishop, et al.
Cancer Treatment Reports|January 1, 1983
Management of patients with metastatic adenocarcinoma of unknown origin: a Southwest Oncology Group studyR A Shildt, P S Kennedy, T T Chen, et al.
Investigational New Drugs|May 1, 1993
Mitoxantrone (dihydroxyanthracenedione) in acute leukemia. An evaluation of two treatment schedules by the Southwest Oncology GroupJ H Saiki, W J Stuckey, J W Athens, et al.
Investigational New Drugs|January 1, 1983
Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast. A Southwest Oncology Group studyF E Smith, N Gad-el-Mawla, B Tranum, et al.
Cancer Treatment Reports|January 1, 1985
Tamoxifen therapy and colorectal adenocarcinoma: a Southwest Oncology Group studyF J Panettiere, C W Groppe, J W Athens, et al.
Cancer Treatment Reports|August 1, 1986
Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group StudyL Dabich, F E Bull, G Beltran, et al.
Cancer|November 15, 1986
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomasJ H Saiki, L H Baker, S E Rivkin, et al.
Breast Cancer Research and Treatment|January 1, 1983
Adjuvant therapy of breast cancer: the Southwest Oncology Group experienceW A Knight, S E Rivkin, H Glucksberg, et al.
Cancer|November 15, 1984
Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group studyB Hoogstraten, N Gad-el-Mawla, T R Maloney, et al.
Pageof 3